At a glance

Study phase

Phase 2 study of an investigational combination therapy.

Population

Adults with advanced non-small cell lung cancer.

Current fit

Designed for patients whose disease has progressed after standard treatment.

Referral model

Sites confirm eligibility directly; this public site does not intake patient data.

What to tell your patient

  • The first step is a site-led screening visit, not an online registration workflow.
  • Participation remains voluntary; informed consent happens with the site team before any study procedures begin.
  • Eligibility depends on protocol criteria, prior treatment history, and screening assessments performed by the research site.
  • If this study is not a fit, ClinicalTrials.gov may help identify other NSCLC studies.

Reference links